Acute Kidney Injury Associated With Cardiac Surgery
AKBAAkebiaCatalyst overview
Research summary
This catalyst tracks a Phase 1 data readout for AKB-9090 (HIF-PH Inhibitor) in Acute Kidney Injury Associated With Cardiac Surgery. The expected timing is based on the latest available company guidance and may change.
01/12/26:- Phase 1 trial in cardiac surgery-associated acute kidney injury planned for H1 2026. 02/26/26:- Ph1 AKB-9090 in healthy volunteers expected H1 2026; topline data by end of 2026. 04/13/26:- First participants dosed in Ph1 SAD/MAD trial. Topline data planned Early 2027. 05/08/26:- Reiterated AKB-9090 Phase 1 SAD/MAD study in up to 70 healthy volunteers; topline data expected early 2027. 08/05/26:- PR No update.
Verification
Confirm timing and program details against the company announcement or filing.